Dan Snyder

Dan Snyder is the current Chair at Oregon Bioscience. Prior to this, they were with CYTOIMAGE DX LLC, The Playbook, and Freenome where they held the position of Biopharma Business Development Strategy from September 2020 to December 2020. From January 2020 to June 2020, they were the Head of Commerical Development at Tasso, Inc. where they were responsible for the commercial development of Tasso's remote blood collection device for clinical trials and diagnotic samples collection. Prior to that, they were with StoneStable, Inc. and MolecularMD where they served as the Chief Executive Officer from January 2006 to August 2019. Under their leadership, MolecularMD became the leader among a competitive field of large cap global cancer diagnostic players and was consistently recognized by the biopharmaceutical industry for its high level of scientific competence and tenacious customer service.

Dan Snyder received their Bachelor of Arts in Economics from the University of Virginia. Dan then pursued their Master of Business Administration - MBA from William & Mary – Raymond A. Mason School of Business. For continuing education, they took a course in Drug and Medical Device Development: A Strategic Approach from MIT xPRO. Dan also has certifications from the Pragmatic Institute in Focus and Foundations, as well as PMC Level II.